Immunomodulation of artemisinin and its derivatives

Science Bulletin - Tập 61 - Trang 1399-1406 - 2016
Wenbo Yao1,2, Feng Wang3, Hui Wang1,2,3,4
1Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
2University of Chinese Academy of Sciences, Shanghai 200031, China
3School of Life Science and Technology, ShanghaiTech University, Shanghai 200031, China
4Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing 100022, China

Tài liệu tham khảo

Chen, 2016, Artemisinin and plant secondary metabolism, Sci Bull, 61, 1, 10.1007/s11434-015-0987-5 Olliaro, 2011, Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa, Am J Trop Med Hyg, 85, 619, 10.4269/ajtmh.2011.11-0154 Robert, 2005, The anti-malarial drug artemisinin alkylates heme in infected mice, Proc Natl Acad Sci USA, 102, 13676, 10.1073/pnas.0500972102 Shi, 2015, Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives, Mediat Inflamm, 2015, 435713, 10.1155/2015/435713 Vennerstrom, 2004, Identification of an antimalarial synthetic trioxolane drug development candidate, Nature, 430, 900, 10.1038/nature02779 Chen, 1994, Topical application of artesunate on guinea pig allergic contact dermatitis, Contact Dermat, 30, 280, 10.1111/j.1600-0536.1994.tb00598.x Cheng, 2011, Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway, PLoS One, 6, 10.1371/journal.pone.0020932 Cheng, 2013, Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models, Allergy, 68, 195, 10.1111/all.12077 Cuzzocrea, 2005, Artemether: a new therapeutic strategy in experimental rheumatoid arthritis, Immunopharmacol Immunotoxicol, 27, 615, 10.1080/08923970500418786 Ho, 2012, Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma, Free Radic Biol Med, 53, 498, 10.1016/j.freeradbiomed.2012.05.021 Hou, 2011, Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses, Arthritis Rheum, 63, 2445, 10.1002/art.30392 Hou, 2009, SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo, Int Immunopharmacol, 9, 1509, 10.1016/j.intimp.2009.09.003 Jin, 2009, A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus, Cell Mol Immunol, 6, 461, 10.1038/cmi.2009.58 Li, 2010, Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation, Int Immunopharmacol, 10, 344, 10.1016/j.intimp.2009.12.006 Li, 2006, Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation, Int Immunopharmacol, 6, 1243, 10.1016/j.intimp.2006.03.004 Li, 2013, Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway, J Lab Clin Med, 161, 89 Mirshafiey, 2006, Design of a new line in treatment of experimental rheumatoid arthritis by artesunate, Immunopharmacol Immunotoxicol, 28, 397, 10.1080/08923970600927447 Shi, 2013, Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation, CNS Neurosci Ther, 19, 262, 10.1111/cns.12066 Sun, 1991, Experimental study on the immunosuppressive effects of qinghaosu and its derivative, Chin J Mod Dev Tradit Med, 11, 37 Wang, 2006, The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release, Antimicrob Agents Chemother, 50, 2420, 10.1128/AAC.01066-05 Wang, 2008, The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses, Br J Pharmacol, 153, 1303, 10.1038/bjp.2008.11 Wang, 2011, Inhibition effect and mechanism of artemisnin on surgically induced endometriosis, J Sichuan Univ Med Sci Ed, 42, 364 Wang, 2011, Effect of artesunate on endotoxin-induced uveitis in rats, Invest Ophthalmol Vis Sci, 52, 916, 10.1167/iovs.10-5892 Wang, 2012, Effects of dihydroartemisinin on collagen II-induced arthritis in rats model, J Sichuan Univ Med Sci Ed, 43, 851 Wang, 2007, Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis, J Immunol, 179, 5958, 10.4049/jimmunol.179.9.5958 Yang, 2012, Immunomodulatory and anti-inflammatory properties of artesunate in experimental colitis, Curr Med Chem, 19, 4541, 10.2174/092986712803251575 Zhao, 2012, Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway, J Immunol, 189, 4417, 10.4049/jimmunol.1200919 Zwang, 2012, Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa, Malar J, 11, 25, 10.1186/1475-2875-11-25 Gasasira, 2008, High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda, Clin Infect Dis, 46, 985, 10.1086/529192 Borrmann, 2005, Shortcourse regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria, Antimicrob Agents Chemother, 49, 3749, 10.1128/AAC.49.9.3749-3754.2005 Guruprasad, 2015, Artesunate ameliorates functional limitations in Freund’s complete adjuvant-induced monoarthritis in rat by maintaining oxidative homeostasis and inhibiting COX-2 expression, Inflammation, 38, 1028, 10.1007/s10753-014-0067-z Hunt, 2015, An extract of the medicinal plant Artemisia annua modulates production of inflammatory markers in activated neutrophils, J Inflamm Res, 8, 9, 10.2147/JIR.S75484 Cao, 2016, Artesunate protects against sepsis-induced lung injury via heme oxygenase-1 modulation, Inflammation, 39, 651, 10.1007/s10753-015-0290-2 Wenisch, 1997, The effect of artemisinin on granulocyte function assessed by flow cytometry, J Antimicrob Chemother, 39, 99, 10.1093/jac/39.1.99 Perlmann, 2002, Malaria and the immune system in humans, Chem Immunol, 80, 229, 10.1159/000058846 Fujiwara, 2005, Macrophages in inflammation, Curr Drug Targets Inflamm Allergy, 4, 281, 10.2174/1568010054022024 Pahl, 1999, Activators and target genes of Rel/NF-kB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239 Prato, 2010, Role of the NF-kB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes, Cell Microbiol, 12, 1780, 10.1111/j.1462-5822.2010.01508.x Shakir, 2011, Artemisinins and immune system, Eur J Pharmacol, 668, 6, 10.1016/j.ejphar.2011.06.044 Yu, 2012, Anti-inflammatory effect and mechanism of artemisinin and dihydroartemisinin, China J Chin Mater Med, 37, 2618 Wang, 2011, Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cdelta/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages, Clin Exp Pharmacol Physiol, 38, 11, 10.1111/j.1440-1681.2010.05454.x Li, 2008, Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation, Int Immunopharmacol, 8, 379, 10.1016/j.intimp.2007.10.024 Hou, 2012, SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development, PLoS One, 7, 10.1371/journal.pone.0032424 Gu, 2012, Artemisinin suppresses sympathetic hyperinnervation following myocardial infarction via anti-inflammatory effects, J Mol Histol, 43, 737, 10.1007/s10735-012-9440-0 Wu, 2012, Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer, Oncol Rep, 27, 101 Li, 2014, Artesunate reduces serum lipopolysaccharide in cecal ligation/puncture mice via enhanced LPS internalization by macrophages through increased mRNA expression of scavenger receptors, Int J Mol Sci, 15, 1143, 10.3390/ijms15011143 Magenta, 2014, Inhibition of metalloproteinase-9 secretion and gene expression by artemisinin derivatives, Acta Trop, 140, 77, 10.1016/j.actatropica.2014.08.008 Kim, 2013, Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages, Food Chem Toxicol, 56, 93, 10.1016/j.fct.2013.02.017 Park, 2012, Artemisinin inhibits lipopolysaccharide-induced interferon-beta production in RAW 264.7 cells: implications on signal transducer and activator of transcription-1 signaling and nitric oxide production, Int Immunopharmacol, 14, 580, 10.1016/j.intimp.2012.09.012 Cho, 2012, Enhanced IL-12p40 production in LPS-stimulated macrophages by inhibiting JNK activation by artemisinin, Arch Pharmacal Res, 35, 1961, 10.1007/s12272-012-1113-8 Wang, 2009, SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kB pathways in RAW 264.7 macrophages, Acta Pharmacol Sin, 30, 1428, 10.1038/aps.2009.138 Konkimalla, 2008, Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells, Nitric Oxide, 19, 184, 10.1016/j.niox.2008.04.008 Sen, 2010, Efficacy of artemisinin in experimental visceral leishmaniasis, Int J Antimicrob Agents, 36, 43, 10.1016/j.ijantimicag.2010.03.008 Xueqin, 2014, Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice, Int Immunopharmacol, 22, 266, 10.1016/j.intimp.2014.07.001 Wang, 2007, Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation, Br J Pharmacol, 150, 652, 10.1038/sj.bjp.0707137 Tatfeng, 2007, CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria, J Vector Borne Dis, 44, 111 Mota, 2011, In vitro evaluation of the genotoxic and cytotoxic effects of artesunate, an anti-malarial drug, in human lymphocytes, Environ Mol Mutagen, 52, 590, 10.1002/em.20659 Yang, 2005, Synthesis and immunosuppressive activity of new artemisinin derivatives. 1. [12(beta or alpha)-dihydroartemisininoxy]phen(ox)yl aliphatic acids and esters, J Med Chem, 48, 4608, 10.1021/jm048979c Veerasubramanian, 2006, Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation, Southeast Asian J Trop Med Public Health, 37, 838 Lee, 2015, Artesunate inhibits proliferation of naive CD4(+) T cells but enhances function of effector T cells, Arch Pharm Res, 38, 1195, 10.1007/s12272-014-0491-5 Zhou, 2005, A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo, Acta Pharmacol Sin, 26, 1352, 10.1111/j.1745-7254.2005.00232.x Wang, 2007, Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo, Eur J Pharmacol, 564, 211, 10.1016/j.ejphar.2007.01.092 Li, 2013, Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell, PLoS One, 8 Li, 2015, Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy, Acta Pharmacol Sin, 36, 188, 10.1038/aps.2014.134 Yang, 1993, Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis, Parasitology, 106, 7, 10.1017/S0031182000074758 Utoh-Nedosa, 2009, Evaluation of the toxic effects of dihydroartemisinin on the vital organs of Wistar albino rats, Am J Pharmacol Toxicol, 4, 169, 10.3844/ajptsp.2009.169.173 Li-Min, 2002, Effect of hydroartemisinin on lupus BXSB mice, Chin J Dermatovenerol Integr Tradit West Med, 1, 19 Langroudi, 2010, A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model, Int Immunopharmacol, 10, 1055, 10.1016/j.intimp.2010.06.005 Botros, 2007, Immuno-histopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether, J Infect, 55, 470, 10.1016/j.jinf.2007.07.022 Zhang, 2014, Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression, Cell Biol Int, 38, 639, 10.1002/cbin.10244 Azimi Mohamadabadi, 2013, Arteether exerts antitumor activity and reduces CD4+ CD25+FOXP3+ T-reg cells in vivo, Iran J Immunol, 10, 139 Noori, 2011, Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo, Cell Immunol, 271, 67, 10.1016/j.cellimm.2011.06.008 Ramacher, 2009, Effect of artesunate on immune cells in ret-transgenic mouse melanoma model, Anti Cancer Drug, 20, 910, 10.1097/CAD.0b013e328330caba Ho, 2014, Artemisinins: pharmacological actions beyond anti-malarial, Pharmacol Ther, 142, 126, 10.1016/j.pharmthera.2013.12.001 Tawfik, 1990, Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice, Int J Immunopharmacol, 12, 385, 10.1016/0192-0561(90)90019-J Hou, 2014, Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis, PLoS One, 9 Yang, 2006, Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(beta or alpha)-dihydroartemisinoxymethyl(or 1’-ethyl)]phenoxyl propionic acids and esters, Bioorg Med Chem, 14, 8043, 10.1016/j.bmc.2006.07.038 Zhang, 2006, Synthesis and immunosuppressive activity of new artemisinin derivatives containing polyethylene glycol group, Acta Pharm Sin B, 41, 65 Wu, 2016, Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation, Cell Mol Immunol, 13, 379, 10.1038/cmi.2015.13 Zhou, 2013, Enhancement effect of dihydroartemisinin on human gammadelta T cell proliferation and killing pancreatic cancer cells, Int Immunopharmacol, 17, 850, 10.1016/j.intimp.2013.09.015 Clark, 2011, Artesunate and artelinic acid: association of embryotoxicity, reticulocytopenia, and delayed stimulation of hematopoiesis in pregnant rats, Birth Defects Res B Dev Reprod Toxicol, 92, 52, 10.1002/bdrb.20282 Li, 2008, Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin, Eur J Pharmacol, 588, 1, 10.1016/j.ejphar.2008.03.041 Xu, 2007, Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes, Rheumatology, 46, 920, 10.1093/rheumatology/kem014 Lei, 2016, Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants, Sci Bull, 61, 3, 10.1007/s11434-015-0929-2